title: Ultraviolet-ozone treatment reduces levels of disease-associated prion protein and prion infectivity.
abstract: BACKGROUND
  Transmissible spongiform encephalopathies (TSEs) are a group of fatal neurodegenerative diseases caused by novel infectious agents referred to as prions. Prions appear to be composed primarily, if not exclusively, of a misfolded isoform of the cellular prion protein. TSE infectivity is remarkably stable and can resist many aggressive decontamination procedures, increasing human, livestock and wildlife exposure to TSEs.
  
  
  RESULTS
  We tested the hypothesis that UV-ozone treatment reduces levels of the pathogenic prion protein and inactivates the infectious agent. We found that UV-ozone treatment decreased the carbon and prion protein content in infected brain homogenate to levels undetectable by dry-ashing carbon analysis or immunoblotting, respectively. After 8 weeks of ashing, UV-ozone treatment reduced the infectious titer of treated material by a factor of at least 105. A small amount of infectivity, however, persisted despite UV-ozone treatment. When bound to either montmorillonite clay or quartz surfaces, PrPTSE was still susceptible to degradation by UV-ozone.
  
  
  CONCLUSIONS
  Our findings strongly suggest that UV-ozone treatment can degrade pathogenic prion protein and inactivate prions, even when the agent is associated with surfaces. Using larger UV-ozone doses or combining UV-ozone treatment with other decontaminant methods may allow the sterilization of TSE-contaminated materials.
authors: Department of Comparative Biosciences, University of Wisconsin - Madison, 1656 Linden Dr, Madison, WI 53706, USA. cjjohnson@usgs.gov
authors: Christopher J
authors: CJ
authors: Johnson
authors: P U P A
authors: PU
authors: Gilbert
authors: Debbie
authors: D
authors: McKenzie
authors: Joel A
authors: JA
authors: Pedersen
authors: Judd M
authors: JM
authors: Aiken